Format

Send to

Choose Destination
See comment in PubMed Commons below
Neurotherapeutics. 2012 Jan;9(1):99-123. doi: 10.1007/s13311-011-0096-3.

Immune mediated diseases and immune modulation in the neurocritical care unit.

Author information

1
Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA.

Abstract

This chapter will review the spectrum of immune-mediated diseases that affect the nervous system and may result in an admission to the neurological intensive care unit. Immunomodulatory strategies to treat acute exacerbations of neurological diseases caused by aberrant immune responses are discussed, but strategies for long-term immunosuppression are not presented. The recommendations for therapeutic intervention are based on a synthesis of the literature, and include recommendations by the Cochrane Collaborative, the American Academy of Neurology, and other key organizations. References from recent publications are provided for the disorders and therapies in which randomized clinical trials and large evidenced-based reviews do not exist. The chapter concludes with a brief review of the mechanisms of action, dosing, and side effects of commonly used immunosuppressive strategies in the neurocritical care unit.

PMID:
22161307
PMCID:
PMC3271148
DOI:
10.1007/s13311-011-0096-3
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Support Center